Average Co-Inventor Count = 7.66
ph-index = 20
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (29 from 822 patents)
2. Abbott Laboratories Corporation (25 from 4,179 patents)
3. Walter and Eliza Hall Institute of Medical Research (8 from 80 patents)
4. Genentech, Inc. (7 from 3,222 patents)
5. Ligand Pharmaceuticals, Inc. (1 from 134 patents)
6. Abbvie Bahamas Limited (6 patents)
7. Abbvie Ireland Unlimited Company (0 patent)
54 patents:
1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
2. 9872861 - Methods of treatment using selective Bcl-2 inhibitors
3. 9493431 - Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases
4. 9493411 - Pyrrole-3-carboxamide bromodomain inhibitors
5. 9359296 - 7-substituted indole Mcl-1 inhibitors
6. 9345702 - Methods of treatment using selective Bcl-2 inhibitors
7. 9315488 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
8. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
9. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
10. 9156856 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
12. 9073855 - BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
13. 9072748 - BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
14. 9067928 - Compounds and methods of use
15. 9045475 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases